Eyebiotech Limited
- Company number
- 13503296
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 9 Jul 2021
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CAN TEMUCIN, Ebru | Director | 11 Jul 2024 | 1 Jul 2026 |
| O'SHAUGHNESSY, Peter James | Director | 1 Jul 2026 | |
| ROGERS, Martin Ian | Director | 11 Jul 2024 | |
| LUCAS, Benjamin Paul | Director | 11 Jul 2024 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Sv7 (Imf) Gp Llp On Behalf Of Sv7 Impact Medicine Fund Lp | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
9 Jul 2021 | 3 Feb 2022 |
| Sv7 (Imf) Gp Llp On Behalf Of Sv7 Impact Medicine Fund Lp | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
3 Feb 2022 | 13 Oct 2023 |
| Merck & Co., Inc. | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
11 Jul 2024 |
Connections
Directors’ other companies
- LUCAS, Benjamin Paul - Director at Merck Sharp & Dohme (UK) Limited
Companies at the same address
- Astro Masons Limited (16500021)
- Cidara Therapeutics UK Limited (10054750)
- City Dynamics Ltd (04361762)
- Merck Sharp & Dohme (UK) Limited (00233687)
- Merck Sharp & Dohme Finance Europe Limited (02866198)
- MSD Limited (05142753)
- MSD R&D Innovation Centre Limited (00955192)
- RD Media Group Ltd (13811347)
- Real Deals Media Limited (06859732)
- Schering-Plough Holdings Limited (02297208)